Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02379351
Other study ID # 77591
Secondary ID
Status Completed
Phase N/A
First received February 20, 2015
Last updated May 17, 2017
Start date July 2015
Est. completion date May 2017

Study information

Verified date August 2016
Source University of Utah
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Non-stress tests (NSTs) are used to monitor the health of babies during pregnancy. These tests are currently conducted in clinics and hospitals. This requires travel to a clinic or hospital, sometimes multiple times per week, in order to receive these tests. Technology has been developed that now allows for NSTs to be done in other locations, including home or work. The Airstrip® Sense4Baby™ NST device has been FDA-approved for use by obstetricians in clinical and hospital settings. The investigators are evaluating the use of the Airstrip® Sense4Baby™ NST device in out-of-hospital settings. The investigators would like to know if this type of monitoring is feasible and acceptable to patients and physicians.


Description:

Phase I of this study enrolls pregnant women with physician-ordered twice-weekly NSTs scheduled in the OB Diagnostic Center at the University of Utah Hospital. Participants receive an in-clinic NST with the Airstrip® Sense4Baby™ device, are taught how to use the device, and asked to demonstrate their ability to use the device. Once the participant successfully demonstrates use of the monitor the device is given to the participant to use at the scheduled time each week. Patients receive educational materials, including a visuals-enhanced, short quick start guide.

For her remote NST monitoring, the patient will receive a virtual NST appointment. At the time of the scheduled appointment, the patient will apply the monitor and the NST will be read by the mid-level provider staffing the testing center after a thirty-minute strip has been recorded and transmitted to the database. The NST will also be interpreted by the maternal-fetal medicine physician, according to the established workflow. The patient will be notified of the result by a telephone call from the mid-level provider and appropriate follow-up arranged according to the NST management algorithm developed for this study. If the patient has trouble with using the device at home, the patient will be able to talk with the mid-level provider via telephone to troubleshoot issues.

The patient will also continue to receive an NST in clinic weekly. These NST schedules will be repeated on a weekly basis until delivery or until the provider discontinues the NST order.

Patients will be contacted after delivery to assess overall satisfaction with the NST at home versus in clinic.

Phase II of this study will enroll the same patient population (pregnant women with physician-ordered twice-weekly NSTs scheduled). Participants in Phase II may receive NSTs up to twice weekly at home. During regularly scheduled obstetric visits (every 1 to 2 weeks depending on gestational age and circumstances), NSTs will be performed on site. However, we will remove the requirement for once weekly on-site testing at the University of Utah Hospital.

The requirement to be within a 60-mile radius of University Hospital will be removed for Phase II participants. Instead, the requirement will be to be within a 60-mile radius of a hospital with an obstetric unit.

Patients will be contacted after delivery to assess overall satisfaction with the NST at home versus in clinic.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Target population: The target population is high-risk pregnant women.

Accessible population: The accessible population is high-risk obstetric patients receiving care throughout the University of Utah Healthcare system and who receive their NSTs at MFDC.

Inclusion Criteria (Phase I):

- Singleton gestation

- Estimated gestational age of 32 0/7 -37 6/7 weeks

- Physician order for twice weekly NSTs

- Live within 60-mile radius of the University of Utah University Hospital

- Reliable access to and connectivity with wireless Internet

- Reliable for communication and follow-up

Exclusion Criteria (Phase I:

- Multifetal gestation

- Maternal age less than 18

- Plans to move prior to end of pregnancy

- No or limited access to internet and/or phone

Inclusion Criteria (Phase II):

- Singleton gestation

- Estimated gestational age of 32 0/7 -37 6/7 weeks

- Physician order for twice weekly NSTs

- Live within 60-mile radius of the University of Utah University Hospital or a hospital with an obstetric inpatient unit

- Reliable access to and connectivity with wireless Internet

- Reliable for communication and follow-up

Exclusion Criteria (Phase II):

- Multifetal gestation

- Maternal age less than 18

- Plans to move prior to end of pregnancy

- No or limited access to internet and/or phone

Study Design


Related Conditions & MeSH terms


Intervention

Device:
In-Home Non-Stress Test Device
Airstrip® Sense4Baby™

Locations

Country Name City State
United States University of Utah Salt Lake City Utah

Sponsors (1)

Lead Sponsor Collaborator
University of Utah

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Integration of Airstrip ® Sense4Baby™ remote non-stress test monitoring into health care system Successful 'integration' will be defined by the ability to schedule remote non-stress tests, mid-level provider visualization and interpretation, communication of conclusion and recommendations to patients, physician visualization and interpretation, and clinical billing. 2 Years
Secondary Frequency of uninterpretable and/or abnormal NSTs requiring on-site follow-up 2 Years
Secondary Patient and provider satisfaction with remote NST compared to on-site NST (questionnaire) 2 Years
Secondary Cost-effectiveness analysis for the health system and for patients 2 Years
See also
  Status Clinical Trial Phase
Completed NCT02627482 - Ambulatory Fetal Heart Rate Monitoring in Small Babies N/A
Active, not recruiting NCT03904979 - Therapeutic Writing to Reduce Stress N/A
Completed NCT02749851 - Placenta Imaging Project
Completed NCT03772080 - Prematurity Education in High Risk Pregnancies N/A
Recruiting NCT06151613 - Continuous Non-invasive Electrophysiological Monitoring in High Risk Pregnancies N/A
Enrolling by invitation NCT05763069 - HOME: Home Monitoring of High-risk Pregnancies
Completed NCT01708746 - Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views N/A
Not yet recruiting NCT04173559 - Sleep and Tracking Effects in Pregnancy Study N/A
Recruiting NCT03152058 - IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy Phase 2
Not yet recruiting NCT06320054 - Preventing Obstetric Complications With Dietary Intervention N/A
Recruiting NCT03220750 - University Hospital Advanced Age Pregnant Cohort N/A
Not yet recruiting NCT04855513 - Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial N/A
Recruiting NCT06414655 - Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
Completed NCT03082664 - Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients N/A
Recruiting NCT06279559 - Music Therapy and High-risk Pregnancy N/A
Not yet recruiting NCT05479357 - Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage N/A
Recruiting NCT04203082 - Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries N/A
Recruiting NCT04783597 - Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies
Recruiting NCT06130150 - Sexual Function in High-risk Pregnant Women
Recruiting NCT03775954 - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise